BioSpace News Archive

Business

Precision Optics Corporation Schedules Fourth Quarter and Fiscal Year 2023 Conference Call for Thursday, September 28, 2023

Precision Optics Corporation, Inc. today announced that it has scheduled a conference call to discuss fourth quarter and fiscal year 2023 financial results on Thursday, September 28, 2023.

September 25, 2023
·
3 min read
Business

IQVIA Appoints Richard Staub III President of Research & Development Solutions

IQVIA™ announced it has appointed Richard Staub III, currently senior advisor to the Chairman and CEO, as president of its Research & Development Solutions business unit.

September 25, 2023
·
2 min read
Policy

Press Release: Once-weekly ALTUVIIIO® approved in Japan as a new class of factor VIII therapy for hemophilia A

The Japanese Ministry of Health, Labor, and Welfare has granted marketing authorization for ALTUVIIIO®, a first-in-class, high-sustained factor VIII replacement therapy.

September 25, 2023
·
8 min read
Business

OJJAARA™ (momelotinib) Now Available from Onco360 For the Treatment of Intermediate or High-Risk Myelofibrosis (MF)

Onco360 has been selected as a pharmacy partner by GlaxoSmithKline for OJJAARA™ (momelotinib). OJJAARA is a kinase inhibitor indicated for the treatment of intermediate or high-risk myelofibrosis (MF), including primary MF or secondary MF [post-polycythemia vera (PV) and post-essential thrombocythemia (ET)], in adults with anemia.

September 25, 2023
·
3 min read